RCM
NDRM

RA Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

RA Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-144,671
Closed -$2.04M – 43
2016
Q1 		$2.04M Hold
144,671
– – 0.26% 39
2015
Q4 		$2.47M Sell
144,671
-280,329
-66% -$5.46M 0.24% 36
2015
Q3 		$8.79M Buy
+425,000
New +$8.72M 1.26% 24

Other funds holding NDRM

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

RA Capital Management's NDRM Position: Q2 2016 in Review

RA Capital Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q2 2016, closing a stake of 144,671 shares — an estimated $2.04M sold.

RA Capital Management first reported a position in NDRM in Q3 2015 and held it in 3 quarters. The position peaked at $8.79M in Q3 2015. 50 funds tracked by Wall St. Rank hold NDRM as of Q2 2016.

  • RA Capital Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q2 2016 after selling out during the quarter.
  • RA Capital Management sold 144,671 NeuroDerm Ltd. Ordinary Shares shares in Q2 2016, an estimated $2.04M.
  • RA Capital Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2015 and held it in 3 quarters.
  • RA Capital Management's NeuroDerm Ltd. Ordinary Shares position peaked at $8.79M in Q3 2015.
  • 50 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q2 2016.

Based on RA Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.